Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta

被引:77
|
作者
Bai, Nan [1 ,2 ]
Miller, Sven A. [1 ]
Andrianov, Grigorii, V [1 ,3 ]
Yates, Max [1 ]
Kirubakaran, Palani [1 ]
Karanicolas, John [1 ]
机构
[1] Fox Chase Canc Ctr, Program Mol Therapeut, Philadelphia, PA 19111 USA
[2] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[3] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan 420008, Russia
基金
美国国家科学基金会;
关键词
Binding energy - Biosynthesis - Computational methods;
D O I
10.1021/acs.jcim.0c01451
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Proteolysis-targeting chimaeras (PROTACs) are molecules that combine a target-binding warhead with an E3 ligase-recruiting moiety; by drawing the target protein into a ternary complex with the E3 ligase, PROTACs induce target protein degradation. While PROTACs hold exciting potential as chemical probes and as therapeutic agents, development of a PROTAC typically requires synthesis of numerous analogs to thoroughly explore variations on the chemical linker; without extensive trial and error, it is unclear how to link the two protein-recruiting moieties to promote formation of a productive ternary complex. Here, we describe a structure-based computational method for evaluating the suitability of a given linker for ternary complex formation. Our method uses Rosetta to dock the protein components and then builds the PROTAC from its component fragments into each binding mode; complete models of the ternary complex are then refined. We apply this approach to retrospectively evaluate multiple PROTACs from the literature, spanning diverse target proteins. We find that modeling ternary complex formation is sufficient to explain both activity and selectivity reported for these PROTACs, implying that other cellular factors are not key determinants of activity in these cases. We further find that interpreting PROTAC activity is best approached using an ensemble of structures of the ternary complex rather than a single static conformation and that members of a structurally conserved protein family can be recruited by the same PROTAC through vastly different binding modes. To encourage adoption of these methods and promote further analyses, we disseminate both the computational methods and the models of ternary complexes.
引用
收藏
页码:1368 / 1382
页数:15
相关论文
共 50 条
  • [31] PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy
    Wang, Lei
    Xiao, Yufeng
    Luo, Yuewan
    Master, Rohan P.
    Mo, Jiao
    Kim, Myung-Chul
    Liu, Yi
    Maharjan, Chandra K.
    Patel, Urvi M.
    De, Umasankar
    Carelock, Madison E.
    Tithi, Tanzia Islam
    Li, Xiangming
    Shaffer, Donald R.
    Guertin, Kevin R.
    Zhuang, Haoyang
    Moser, Emily
    Smalley, Keiran S. M.
    Lv, Dongwen
    Zhou, Daohong
    Zheng, Guangrong
    Zhang, Weizhou
    JOURNAL OF EXPERIMENTAL MEDICINE, 2024, 221 (03):
  • [32] Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
    Mares, Alina
    Miah, Afjal H.
    Smith, Ian E. D.
    Rackham, Mark
    Thawani, Aditya R.
    Cryan, Jenni
    Haile, Pamela A.
    Votta, Bartholomew J.
    Beal, Allison M.
    Capriotti, Carol
    Reilly, Michael A.
    Fisher, Don T.
    Zinn, Nico
    Bantscheff, Marcus
    MacDonald, Thomas T.
    Vossenkamper, Anna
    Dace, Phoebe
    Churcher, Ian
    Benowitz, Andrew B.
    Watt, Gillian
    Denyer, Jane
    Scott-Stevens, Paul
    Harling, John D.
    COMMUNICATIONS BIOLOGY, 2020, 3 (01)
  • [33] PROTAC-Mediated Selective Degradation of Cytosolic Soluble Epoxide Hydrolase Enhances ER Stress Reduction
    Wang, Yuxin
    Morisseau, Christophe
    Takamura, Akihiro
    Wan, Debin
    Li, Dongyang
    Sidoli, Simone
    Yang, Jun
    Wolan, Dennis W.
    Hammock, Bruce D.
    Kitamura, Seiya
    ACS CHEMICAL BIOLOGY, 2023, 18 (04) : 884 - 896
  • [34] Benchmarking Methods for PROTAC Ternary Complex Structure Prediction
    Rovers, Evianne
    Schapira, Matthieu
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2024, 64 (15) : 6162 - 6173
  • [35] Addressing the Enzyme-independent tumor-promoting function of NAMPT via PROTAC-mediated degradation
    Zhu, Xiaotong
    Liu, Haixia
    Chen, Li
    Wu, Chenxu
    Liu, Xuesong
    Cang, Yong
    Jiang, Biao
    Yang, Xiaobao
    Fan, Gaofeng
    CELL CHEMICAL BIOLOGY, 2022, 29 (11) : 1616 - +
  • [36] Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
    Cantley, Jennifer
    Ye, Xiaofen
    Rousseau, Emma
    Januario, Tom
    Hamman, Brian D.
    Rose, Christopher M.
    Cheung, Tommy K.
    Hinkle, Trent
    Soto, Leofal
    Quinn, Connor
    Harbin, Alicia
    Bortolon, Elizabeth
    Chen, Xin
    Haskell, Roy
    Lin, Eva
    Yu, Shang-Fan
    Del Rosario, Geoff
    Chan, Emily
    Dunlap, Debra
    Koeppen, Hartmut
    Martin, Scott
    Merchant, Mark
    Grimmer, Matt
    Broccatelli, Fabio
    Wang, Jing
    Pizzano, Jennifer
    Dragovich, Peter S.
    Berlin, Michael
    Yauch, Robert L.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [37] PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia
    Perzolli, Alicia
    Steinebach, Christian
    Kroenke, Jan
    Guetschow, Michael
    Zwaan, C. Michel
    Barneh, Farnaz
    Heidenreich, Olaf
    CANCERS, 2025, 17 (02)
  • [38] Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
    Jennifer Cantley
    Xiaofen Ye
    Emma Rousseau
    Tom Januario
    Brian D. Hamman
    Christopher M. Rose
    Tommy K. Cheung
    Trent Hinkle
    Leofal Soto
    Connor Quinn
    Alicia Harbin
    Elizabeth Bortolon
    Xin Chen
    Roy Haskell
    Eva Lin
    Shang-Fan Yu
    Geoff Del Rosario
    Emily Chan
    Debra Dunlap
    Hartmut Koeppen
    Scott Martin
    Mark Merchant
    Matt Grimmer
    Fabio Broccatelli
    Jing Wang
    Jennifer Pizzano
    Peter S. Dragovich
    Michael Berlin
    Robert L. Yauch
    Nature Communications, 13
  • [39] Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated Degradation
    Buhimschi, Alexandru D.
    Armstrong, Haley A.
    Toure, Momar
    Jaime-Figueroa, Saul
    Chen, Timothy L.
    Lehman, Amy M.
    Woyach, Jennifer A.
    Johnson, Amy J.
    Byrd, John C.
    Crews, Craig M.
    BIOCHEMISTRY, 2018, 57 (26) : 3564 - 3575
  • [40] Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
    Burslem, George M.
    Schultz, Anna Reister
    Bondeson, Daniel P.
    Eide, Christopher A.
    Stevens, Samantha L. Savage
    Druker, Brian J.
    Crews, Craig M.
    CANCER RESEARCH, 2019, 79 (18) : 4744 - 4753